Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer: Part 1: Assessment and conventional radiotherapy

ONCOLOGY

Volumn 20, Issue 7, 2006, Pages 727-736

  Decker, Roy H ^a   Tanoue, Lynn T ^a   Colasanto, Joseph M ^a   Detterbeck, Frank C ^a   Wilson, Lynn D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADVANCED CANCER; AGE DISTRIBUTION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; COMORBIDITY; ESOPHAGITIS; EVALUATION RESEARCH; HUMAN; LOBECTOMY; LUNG DISEASE; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MEDIASTINUM LYMPH NODE; PATIENT ASSESSMENT; PATIENT CARE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOFREQUENCY ABLATION; RADIOSURGERY; REVIEW; STEREOTAXIC SURGERY; TREATMENT FAILURE; LUNG TUMOR; PATHOLOGY; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 33750629207     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56:106-130, 2006.
2. Mountain CF: The international system for staging lung cancer. Semin Surg Oncol 18:106-115, 2000.
3. McGarry RC, Song G, des Rosiers P, et al: Observation-only management of early stage, medically inoperable lung cancer: Poor outcome. Chest 121:1155-1158, 2002.
4. Chadha AS, Ganti AK, Sohi JS, et al: Survival in untreated early stage non-small cell lung cancer. Anticancer Res 25:3517-3520, 2005.
5. Wisnivesky JP, Bonomi M, Henschke C, et al: Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 128:1461-1467, 2005.
6. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004.
7. Blum RH: Adjuvant chemotherapy for lung cancer - a new standard of care. N Engl J Med 350:404-405, 2004.
8. Winton T, Livingston R, Johnson D, et al: Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352:2589-2597, 2005.
9. Kato H, Ichinose Y, Ohta M, et al: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713-1721, 2004.
10. Pisters KM: Adjuvant chemotherapy for non-small-cell lung cancer - the smoke clears. N Engl J Med 352:2640-2642, 2005.
11. Ries LAG, Eisner MP, Kosary CL, et al: SEER Cancer Statistics Review, 1975-2002. National Cancer Institute, Bethesda, Md, 2005.
12. Brock MV, Kim MP, Hooker CM, et al: Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: A 22-year experience. Ann Thorac Surg 77:271-277, 2004.
13. Port JL, Kent M, Korst RJ, et al: Surgical resection for lung cancer in the octogenarian. Chest 126:733-738, 2004.
14. Fukuse T, Satoda N, Hijiya K, et al: Importance of a comprehensive geriatric assessment in prediction of complications following thoracic surgery in elderly patients. Chest 127:886-891, 2005.
15. Eagle KA, Berger PB, Calkins H, et al: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 39:542-553, 2002.
16. Gaensler EA, Cugell DW, Lindgren I, et al: The role of pulmonary insufficiency in mortality and invalidism following surgery for pulmonary tuberculosis. J Thorac Surg 29:163-187, 1955.
17. BTS guidelines: Guidelines on the selection of patients with lung cancer for surgery. Thorax 56:89-108, 2001.
18. Wyser C, Stulz P, Soler M, et al: Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med 159:1450-1456, 1999.
19. Tanoue LT: Preoperative evaluation of the high-risk surgical patient for lung cancer resection. Semin Respir Crit Care Med 21:421-432, 2000.
20. Tanoue LT, Ponn RB: Therapy for stage I and stage II non-small cell lung cancer. Clin Chest Med 23:173-190, 2002.
21. Datta D, Lahiri B: Preoperative evaluation of patients undergoing lung resection surgery. Chest 123:2096-2103, 2003.
22. Beckles MA, Spiro SG, Colice GL, et al: The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 123:105S-114S, 2003.
23. Ferguson MK, Little L, Rizzo L, et al: Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg 96:894-900, 1988.
24. Handy JR Jr, Asaph JW, Skokan L, et al: What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest 122:21-30, 2002.
25. Kristersson S, Lindell SE, Svanberg L: Prediction of pulmonary function loss due to pneumonectomy using 133 Xe-radiospirometry. Chest 62:694-698, 1972.
26. Wernly JA, DeMeester TR, Kirchner PT, et al: Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. J Thorac Cardiovasc Surg 80:535-543, 1980.
27. Corris PA, Ellis DA, Hawkins T, et al: Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy. Thorax 42:285-291, 1987.
28. Nezu K, Kushibe K, Tojo T, et al: Recovery and limitation of exercise capacity after lung resection for lung cancer. Chest 113:1511-1516, 1998.
29. Gass GD, Olsen GN: Preoperative pulmonary function testing to predict postoperative morbidity and mortality. Chest 89:127-135, 1986.
30. Nakahara K, Ohno K, Hashimoto J, et al: Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer. Ann Thorac Surg 46:549-552, 1988.
31. Markos J, Mullan BP, Hillman DR, et al: Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 139:902-910, 1989.
32. Olsen GN, Bolton JW, Weiman DS, et al: Stair climbing as an exercise test to predict the postoperative complications of lung resection. Two years' experience. Chest 99:587-590, 1991.
33. Pollock M, Roa J, Benditt J, et al: Estimation of ventilatory reserve by stair climbing. A study in patients with chronic airflow obstruction. Chest 104:1378-1383, 1993.
34. Pate P, Tenholder MF, Griffin JP, et al: Preoperative assessment of the high-risk patient for lung resection. Ann Thorac Surg 61:1494-1500, 1996.
35. Bechard D, Wetstein L: Assessment of exercise oxygen consumption as preoperative criterion for lung resection. Ann Thorac Surg 44:344-349, 1987.
36. Richter LK, Svendsen UG, Milman N, et al: Exercise testing in the preoperative evaluation of patients with bronchogenic carcinoma. Eur Respir J 10:1559-1565, 1997.
37. Morice RC, Peters EJ, Ryan MB, et al: Exercise testing in the evaluation of patients at high risk for complications from lung resection. Chest 101:356-361, 1992.
38. Bolliger CT, Soler M, Stulz P, et al: Evaluation of high-risk lung resection candidates: pulmonary haemodynamics versus exercise testing. A series of five patients. Respiration 61:181-186, 1994.
39. Walsh GL, Morice RC, Putnam JB Jr, et al: Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg 58:704-710, 1994.
40. Brutsche MH, Spiliopoulos A, Bolliger CT, et al: Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J 15:828-832, 2000.
41. Bolliger CT, Jordan P, Soler M, et al: Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med 151:1472-1480, 1995.
42. Smith TP, Kinasewitz GT, Tucker WY, et al: Exercise capacity as a predictor of post-thoracotomy morbidity. Am Rev Respir Dis 129:730-734, 1984.
43. Holden DA, Rice TW, Stelmach K, et al: Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest 102:1774-1779, 1992.
44. Win T, Jackson A, Sharples L, et al: Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest 127:1159-1165, 2005.
45. Martini N, Bains MS, Burt ME, et al: Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109:120-129, 1995.
46. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615-622, 1995.
47. Smythe WR: Treatment of stage I non-small cell lung carcinoma. Chest 123:181S-187S, 2003.
48. Ware JH: The National Emphysema Treatment Trial - how strong is the evidence? N Engl J Med 348:2055-2056, 2003.
49. Russi EW, Bloch KE, Weder W: Lung volume reduction surgery: What can we learn from the National Emphysema Treatment Trial? Eur Respir J 22:571-573, 2003.
50. Ojo TC, Martinez F, Paine R III, et al: Lung volume reduction surgery alters management of pulmonary nodules in patients with severe COPD. Chest 112:1494-1500, 1997.
51. McKenna RJ Jr, Fischel RJ, Brenner M, et al: Combined operations for lung volume reduction surgery and lung cancer. Chest 110:885-888, 1996.
52. Haffty BG, Goldberg NB, Gerstley J, et al: Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 15:69-73, 1988.
53. Sandler HM, Curran WJ Jr, Turrisi AT III: The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 19:9-13, 1990.
54. Zhang HX, Yin WB, Zhang LJ, et al: Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 14:89-94, 1989.
55. Hayakawa K, Mitsuhashi N, Saito Y, et al: Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26:137-142, 1999.
56. Noordijk EM, vd Poest Clement E, Hermans J, et al: Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 13:83-89, 1988.
57. Krol AD, Aussems P, Noordijk EM, et al: Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 34:297-302, 1996.
58. Graham MV, Purdy JA, Emami B, et al: Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 33:993-1000, 1995.
59. Talton BM, Constable WC, Kersh CR: Curative radiotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 19:15-21, 1990.
60. Morita K, Fuwa N, Suzuki Y, et al: Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients. Radiother Oncol 42:31-36, 1997.
61. Kaskowitz L, Graham MV, Emami B, et al: Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27:517-523, 1993.
62. Kupelian PA, Komaki R, Allen P: Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36:607-613, 1996.
63. Sibley GS: Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: smaller volumes and higher doses - a review. Cancer 82:433-438, 1998.
64. Zierhut D, Bettscheider C, Schubert K, et al: Radiation therapy of stage I and II non-small cell lung cancer (NSCLC). Lung Cancer 34(suppl 3):S39-S43, 2001.
65. Dosoretz DE, Katin MJ, Blitzer PH, et al: Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 24:3-9, 1992.
66. Slotman BJ, Njo KH, Karim AB: Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 29:33-37, 1994.
67. Gauden S, Ramsay J, Tripcony L: The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108:1278-1282, 1995.
68. Cheung PC, Yeung LT, Basrur V, et al: Accelerated hypofractionation for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54:1014-1023, 2002.
69. Jeremic B, Shibamoto Y, Acimovic L, et al: Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 38:521-525, 1997.
70. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 41:41-44, 1996.
71. Firat S, Bousamra M, Gore E, Byhardt RW: Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52:1047-1057, 2002.
72. Lagerwaard FJ, Senan S, van Meerbeeck JP, et al: Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? Radiother Oncol 63:151-157, 2002.
73. Bradley JD, Wahab S, Lockett MA, et al: Elective nodal failures are uncommon in medically inoperable patients with stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 56:342-347, 2003.
74. Langendijk JA, Aaronson NK, de Jong JM, et al: Quality of life after curative radiotherapy in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 53:847-853, 2002.
75. Cheung PC, Mackillop WJ, Dixon P, et al: Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48:703-710, 2000.
76. Chen M, Hayman JA, Ten Haken RK, et al: Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: Is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys 64:120-126, 2005.
77. Graham MV, Purdy JA, Emami B, et al: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45:323-329, 1999.
78. Perez CA, Pajak TF, Rubin P, et al: Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59:1874-1881, 1987.
79. Bradley J, Graham MV, Winter K, et al: Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61:318-328, 2005.
80. Rosenzweig KE, Fox JL, Yorke E, et al: Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 103:2118-2127, 2005.
81. Narayan S, Henning GT, Ten Haken RK, et al: Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 44:79-88, 2004.
82. Socinski MA, Morris DE, Halle JS, et al: Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: A dose-escalation phase I trial. J Clin Oncol 22:4341-4350, 2004.
83. Lee RE, Carr DT, Childs DS Jr: Comparison of split-course radiation therapy and continuous radiation therapy for unresectable bronchogenic carcinoma: 5 year results. AJR Am J Roentgenol 126:116-122, 1976.
84. Routh A, Hickman BT, Khansur T: Report of a prospective trial - split course versus conventional radiotherapy in the treatment of non small cell lung cancer. Radiat Med 13:115-119, 1995.
85. Belderbos JS, De JK, Heemsbergen WD, et al: First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66:119-126, 2003.
86. Saunders M, Dische S, Barrett A, et al: Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. CHART steering committee. Radiother Oncol 52:137-148, 1999.